Document Detail


Risk of leukemia in children treated with human growth hormone: review and reanalysis.
MedLine Citation:
PMID:  9255225     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Data have suggested that any increased incidence of leukemia in growth-hormone (GH)-treated patients was limited to those with known risk factors for leukemia. However, previous studies may have overestimated the numbers of patient-years of risk by not excluding data from "positive-risk-factor" patients. This risk was reanalyzed by using data on children in the National Cooperative Growth Study (NCGS), with correction for this possible confounding factor. METHODS: The risk of leukemia in GH-treated patients without known risk factors was determined by using patient-years of GH therapy and patient-years since first exposure to GH therapy and the values obtained were compared with values from the Surveillance, Epidemiology, and End Results program of the National Cancer Institute. RESULTS: Three cases of leukemia in patients without known risk factors were found in the NCGS database; 3.42 cases would be expected in the 119,846 patient-years in the analysis using time since GH exposure. Two of these cases of leukemia occurred during GH therapy (67,773 patient-years); 2.13 cases would be expected. CONCLUSION: Excluding data on patients with known risk factors for leukemia provides a more accurate estimate of the risks in GH-treated patients. The incidence of leukemia in these patients is comparable to that in the general population of age-matched children.
Authors:
D B Allen; A C Rundle; D A Graves; S L Blethen
Related Documents :
19781775 - Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q2...
15339675 - Prognostic implications of wilms' tumor gene (wt1) expression in patients with de novo ...
6953605 - Acute leukemia as a transformation after polycythemia vera.
3463435 - Treatment of acute leukaemia with m-amsa in combination with cytosine arabinoside.
22684485 - Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
14144545 - Photomicrographic study on the capillary nail beds of muscular dystrophy patients.
Publication Detail:
Type:  Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  131     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1997 Jul 
Date Detail:
Created Date:  1997-09-04     Completed Date:  1997-09-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S32-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, University of Wisconsin Medical School, Madison, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Case-Control Studies
Child
Child, Preschool
Confounding Factors (Epidemiology)
Female
Human Growth Hormone / adverse effects*
Humans
Incidence
Information Systems
Leukemia / chemically induced*
Male
National Institutes of Health (U.S.)
Risk Factors
SEER Program
Time Factors
United States
Chemical
Reg. No./Substance:
12629-01-5/Human Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Growth hormone is safe in children after renal transplantation.
Next Document:  Endocrine late effects of childhood cancers.